Keyword: Dana-Farber Cancer Institute
At the annual ASH meeting, oncologists at the Dana-Farber Cancer Institute demonstrated how simple blood tests may hold promise for managing multiple myeloma.
Daiichi Sankyo has added a preclinical lung cancer collaboration with Dana-Farber Cancer Institute to its fast-growing list of oncology alliances.
Dr. Richard Gaynor will leave his position as one of the top execs of Eli Lilly’s Oncology division at the start of next year as the company employs new blood to try to bolster its cancer R&D.
Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.